Sonoma Pharmaceuticals files updated investor presentation; no specific financial or operational details disclosed

Sonoma Pharmaceuticals, Inc.

Filing includes an updated investor presentation as of January 2026, furnished as Exhibit 99.1.
The presentation content is not fully provided; only legal disclaimers are visible in the filing.
No new financial results, guidance, or material events are disclosed in the filing text.
The presentation may contain updates on commercial progress, but specifics are not available from this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.